April 2026 Regulatory Roundup: FDA Compounding, New Approvals, and Stewardship Erica Wassack, PharmD, DICVP, FACVP Regulatory & Governmental Affairs Liaison The following updates summarize recent FDA activity relevant to pharmacy and veterinary practice. Please review and share with your team as appropriate. FDA Compounding Listening Session — February 27, 2026 The FDA hosted a formal [...]
Practical Application of Acupuncture in Laboratory Animal Medicine This knowledge-based, on-demand webinar provides pharmacists, pharmacy technicians, veterinarians, and veterinary technicians with an introduction to the practical application of acupuncture in laboratory animal medicine. The program explores acupuncture as a complementary therapy within veterinary and laboratory animal care, with a focus on [...]
Medicating Without Fear to Improve Veterinary Patient Outcomes Non-Aversive Methods for Drug Administration and Dosing of Animals and Pets to Improve Compliance $30 ACVP Members; $40 Non-Members; Special Pricing for Technicians and Students This activity is approved for 1 hour of ACPE accredited CE for Pharmacists and Pharmacy Technicians. Overview —Medicating animals can be [...]
New Generic Approval: Methimazole Coated Tablets (ANADA 200-814) Important Update for ACVP Members and Veterinary Pharmacy Professionals The FDA has approved Methimazole Coated Tablets under ANADA 200-814, a generic equivalent to the pioneer product Felimazole® (NADA 141-292), for the treatment of hyperthyroidism in cats. This approval offers veterinary pharmacy professionals a reliable, cost-effective [...]
Recent Veterinary Drug Approval Updates: What Pharmacists Should Know For ACVP Members and Veterinary Pharmacy Professionals Two recent FDA actions bring noteworthy changes to veterinary pharmacotherapy—particularly for pharmacists involved in compounding and those managing inventory of critical-use medications in clinical settings. ________________________________________ Felicyn-CA1 (sirolimus) – Conditional Approval for Management of Ventricular Hypertrophy in Cats [...]
Labeling Update Alert: Librela® (bedinvetmab injection), NADA 141-562 Overview Librela® (bedinvetmab injection), the first monoclonal antibody approved in the U.S. to control osteoarthritis pain in dogs, received important label updates on February 18, 2025, under NADA 141-562. These changes reflect data gathered from real-world post-approval use since its U.S. launch in October 2023. [...]
Supporting Veterinary Prescribing: Challenges and Solutions Veterinarians commonly prescribe medications for a variety of medical conditions. Medications are typically prescribed and filled in the clinic setting, typically at the time an animal is examined by a veterinarian. Veterinarians face a number of challenges in regard to prescribing including variation in dosing and clinical presentations [...]
Unapproved Pet Medications Are No Bargain—Here’s Why Your pet’s health and well-being are paramount, and when it comes to managing serious conditions like idiopathic epilepsy and seizures, the stakes couldn’t be higher. Recently, the FDA issued warnings to six online sellers of unapproved drugs that claim to treat or control seizures in dogs [...]
Improving Antibiotic Use In Companion Animal Medicine: A Team-Based Approach This webinar was originally presented on January 12, 2024. Price: $40 ACVP Members; $60 Non-Members Overview – Research suggests that veterinarians often prescribe antibiotics to animals in an unsupported manner. Such prescribing patterns are concerning as they promote the development of antibiotic resistance in [...]
Improving Antibiotic Use In Companion Animal Medicine: A Team-Based Approach Date and Time of CE Activity January 12, 2024 2 pm EST/1 pm CST/12 noon MST/11 am PST Overview – Research suggests that veterinarians often prescribe antibiotics to animals in an unsupported manner. Such prescribing patterns are concerning as they promote the development of antibiotic resistance [...]